Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,938
Closed -$424K 76
2017
Q3
$424K Sell
6,938
-3,507
-34% -$213K 0.37% 61
2017
Q2
$638K Sell
10,445
-95
-0.9% -$5.78K 0.48% 53
2017
Q1
$639K Buy
10,540
+2,263
+27% +$137K 0.55% 50
2016
Q4
$465K Buy
8,277
+788
+11% +$46.1K 0.4% 72
2016
Q3
$446K Sell
7,489
-188
-2% -$11K 0.46% 63
2016
Q2
$422K Sell
7,677
-927
-11% -$49.3K 0.39% 75
2016
Q1
$433K Sell
8,604
-1,236
-13% -$60.5K 0.43% 71
2015
Q4
$496K Buy
+9,840
New +$496K 0.5% 58

Other funds holding MRK

Girard Securities's MRK Position: Q4 2017 in Review

Girard Securities sold out of Merck (MRK) in Q4 2017, closing a stake of 6,938 shares — an estimated $424K sold.

Girard Securities first reported a position in MRK in Q4 2015 and held it in 8 quarters. The position peaked at $639K in Q1 2017. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Girard Securities reported no remaining Merck position as of Q4 2017 after selling out during the quarter.
  • Girard Securities sold 6,938 Merck shares in Q4 2017, an estimated $424K.
  • Girard Securities first reported a position in Merck in Q4 2015 and held it in 8 quarters.
  • Girard Securities's Merck position peaked at $639K in Q1 2017.
  • 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Girard Securities's 13F filing for Q4 2017.